FOLD – amicus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable? [Yahoo! Finance]
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? [Yahoo! Finance]
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $19.00. They now have an "overweight" rating on the stock.
Form ARS AMICUS THERAPEUTICS, For: Dec 31
Form DEF 14A AMICUS THERAPEUTICS, For: Jun 06
Form DEFA14A AMICUS THERAPEUTICS,
Form 4 AMICUS THERAPEUTICS, For: Apr 15 Filed by: Prout Samantha
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.